MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Merck & Co., Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$143.63−2.32 (-1.59%)
Close on Oct 19, 2026
- Market cap
- $354.77B
- P/E (TTM)
- 114.9
- Dividend yield
- 2.28%
Merck statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Merck | Industry median |
|---|---|---|
| Market Cap | $354.36B | $197.05M |
| Enterprise Value | $401.18B | $106.56M |
| PE Ratio | 114.90 | 20.52 |
| PS Ratio | 5.32 | 3.93 |
| PB Ratio | 8.45 | 2.14 |
| P/FCF Ratio | 22.06 | 18.25 |
| P/OCF Ratio | 17.75 | 13.78 |
Enterprise value
| Measure | Merck | Industry median |
|---|---|---|
| EV / Sales | 6.03 | 2.69 |
| EV / FCF | 24.98 | 21.02 |
Income (trailing twelve months)
| Measure | Merck | Industry median |
|---|---|---|
| Revenue | $66.57B | $57.94M |
| Gross Profit | $48.57B | $90.47M |
| Pretax Income | $5.95B | -$14.45M |
| Net Income | $3.17B | -$22.46M |
| EPS (Diluted) | $1.25 | -$0.83 |
Margins
| Measure | Merck | Industry median |
|---|---|---|
| Gross Margin | 73.0% | 52.3% |
| Pretax Margin | 8.94% | -13.0% |
| Profit Margin | 4.77% | -39.2% |
| FCF Margin | 24.1% | -8.85% |
Returns
| Measure | Merck | Industry median |
|---|---|---|
| Return on Equity (ROE) | 6.98% | -53.1% |
| Return on Assets (ROA) | 2.57% | -41.0% |
Growth
| Measure | Merck | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 4.64% | 6.01% |
| Net Income Growth (YoY) | -80.7% | -37.7% |
| EPS Growth (YoY) | -80.7% | -29.2% |
| FCF Growth (YoY) | 9.11% | 2.34% |
| Revenue Growth (3Y CAGR) | 3.12% | 2.25% |
| Revenue Growth (5Y CAGR) | 9.38% | 6.42% |
| EPS Growth (3Y CAGR) | 8.43% | -0.17% |
| EPS Growth (5Y CAGR) | 21.2% | 3.77% |
Balance sheet
| Measure | Merck | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $7.14B | $62.42M |
| Total Debt | $53.91B | $120.13M |
| Net Cash (Debt) | -$46.77B | $15.68M |
| Net Cash Per Share | -$18.95 | $0.65 |
| Equity (Book Value) | $41.93B | $48.79M |
| Book Value Per Share | $17.00 | $1.36 |
| Tangible Book Value | -$4.63B | $23.06M |
| Working Capital | $8.95B | $75.77M |
Financial position
| Measure | Merck | Industry median |
|---|---|---|
| Current Ratio | 1.32 | 3.30 |
| Quick Ratio | 0.71 | 2.39 |
| Debt / Equity | 1.29 | 0.51 |
| Debt / FCF | 3.36 | 5.05 |
Cash flow (trailing twelve months)
| Measure | Merck | Industry median |
|---|---|---|
| Operating Cash Flow | $19.97B | -$12.35M |
| Capital Expenditures | -$3.90B | -$1.06M |
| Free Cash Flow | $16.06B | -$20.28M |
| FCF Per Share | $6.51 | -$0.41 |
Efficiency
| Measure | Merck | Industry median |
|---|---|---|
| Asset Turnover | 0.54 | 0.38 |
| Inventory Turnover | 2.81 | 2.67 |
| Revenue Per Employee | $887.59K | $398.96K |
| Profits Per Employee | $42.31K | -$732.08K |
| Employee Count | 75,000 | 73 |
Dividends and yields
| Measure | Merck | Industry median |
|---|---|---|
| Earnings Yield | 0.90% | -21.2% |
| FCF Yield | 4.53% | -7.64% |
| Dividend Yield | 2.28% | 1.83% |
| Buyback Yield | 1.19% | -0.58% |
| Shareholder Yield | 3.47% | 0.00% |
| Dividend Per Share | $3.28 | $0.83 |
| Dividend Growth (YoY) | 5.13% | 2.37% |
| Years of Dividend Growth | 11 | 0 |
| Payout Ratio | 261.5% | 47.7% |
| FCF Payout Ratio | 51.7% | 51.6% |
Shares
| Measure | Merck | Industry median |
|---|---|---|
| Shares Outstanding | 2,467,170,000 | 59,128,900 |
| Shares Change (YoY) | -1.92% | 11.1% |
| Float | 2,465,880,000 | 48,744,500 |
| Shares Held by Insiders | 0.05% | 11.8% |
| Shares Held by Institutions | 80.3% | 59.4% |
Taxes
| Measure | Merck | Industry median |
|---|---|---|
| Income Tax | $2.78B | $91.50K |
| Effective Tax Rate | 46.7% | 20.6% |
Scores
| Measure | Merck | Industry median |
|---|---|---|
| Graham Number | $21.86 | $17.36 |
| Graham Upside | -84.8% | -45.5% |
| Altman Z-Score | 3.70 | 0.10 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Merck's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.